This clinical trial is double blind, randomized with Placebo-controlled groups that will be carried out in Sina hospital in Ahvaz. Participants will be women with postdate pregnancy who require labor induction. Eligible women are interviewed following a visit by gynecologist and study goals are explained completely for them. Written agreement will be obtained and their demographic characteristics will be recorded by the researcher. After physical examination, cervix bishop score is determined and then 40 mg Isosorbite mononitrate or placebo prepared by pharmacist will be administered into the posterior vaginal fornix. Mothers will be under supervision for 2 hours before they are allowed to go home.The time of next visit is set and they are advised to avoid taking any drug or intercourse. They will be asked to return immediately to hospital if there are some painful contractions, premature rupture of membrane, vaginal bleeding or bloody show. Nevertheless all subjects should return after 12 hours and will all of them will be admitted. The second dose of drug or placebo is administrated and after 24 hours from the first visit, the bishop score of cervix is determined and classic induction with oxytocin will begin if they are not in active labor. Bishop score changes, duration of delivery induction, time from start of oxytocin to active phase, duration of active phase, second and third stage of labor, the amount of consumed oxytocin, mode of delivery, any kind of maternal and fetal outcome will be registered.